{"@type": "dcat:Dataset", "accessLevel": "public", "accrualPeriodicity": "R/P1Y", "bureauCode": ["009:10"], "contactPoint": {"@type": "vcard:Contact", "fn": "Division of Drug Information", "hasEmail": "mailto:druginfo@fda.hhs.gov"}, "description": "Carvedilol Phosphate is a generic prescription medication available as extended-release oral capsules in strengths of 10mg, 20mg, 40mg, and 80mg. It acts as an alpha and beta adrenergic blocker, commonly used to treat high blood pressure and heart failure by relaxing blood vessels and reducing heart workload. Manufactured by Amneal Pharmaceuticals. This information was generated using AI and is provided for informational and research purposes only.", "distribution": [{"@type": "dcat:Distribution", "description": "\n        Access the FDA dataset for Carvedilol phosphate \u2014 ANDA 204717 submitted by Mylan Institutional LLC\n    ", "downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204717", "mediaType": "text/html", "title": "Carvedilol phosphate"}], "identifier": "ANDA204717", "issued": "2016-09-16", "keyword": ["drug", "drug-manufacturers", "health-care", "public-health", "drug-safety"], "landingPage": "https://www.fda.gov/drugs", "license": "https://open.fda.gov/license", "modified": "2025-03-17", "programCode": ["009:002"], "publisher": {"@type": "org:Organization", "name": "U.S. Food and Drug Administration"}, "theme": ["FDA"], "title": "Carvedilol phosphate"}